Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Paradigm Biopharmaceuticals Ltd (PBIGF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Stock Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	PBIGF
Company	Paradigm Biopharmaceuticals Ltd
Price Information
Exchange	OTC US
Open	0.3807
High	0.3807
Low	0.3807
Last	0.3807
Change	+0.0307
% Change	+8.77%
Volume	1,000
20-Day Average Volume	8,725
Previous Close	0.3500
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	0.2301
20-Day Raw Stochastic	100.00%
20-Day Relative Strength	56.64%
Weighted Alpha	N/A
Today's Opinion	N/A
Previous Opinion	N/A
Last Month's Opinion	N/A
Performance
5-Days
%Chg	+26.90% since 01/17/25
Low	0.2959 on 01/29/25
High	0.3807 on 02/19/25
1-Month
%Chg	+26.90% since 01/17/25
Low	0.2959 on 01/29/25
High	0.3807 on 02/19/25
3-Month
%Chg	+170.96% since 10/30/24
Low	0.2637 on 01/06/25
High	0.3807 on 02/19/25
6-Month
%Chg	+140.95% since 08/19/24
Low	0.1147 on 10/01/24
High	0.3807 on 02/19/25
Key Statistics
Market Capitalization, $K	N/A
Shares Outstanding, K	N/A
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	N/A
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	N/A
Ratios
Price/Earnings ttm	N/A